An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA
Article in Clinical Drug Investigation (May 2020)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Clinical Drug Investigation (May 2020)
Book chapter (December 2019)
Article in Melanoma Management (October 2019)